|
Clinical trials Randomized controlled (CONSORT agreement)
Citations 171-180 of 248 total displayed.
|
Past content
(since Mar 2001):
|
- BRIEF COMMUNICATIONS
A randomized trial of botulinum toxin A for treatment of drooling
- A. Lipp, T. Trottenberg, T. Schink, A. Kupsch, and G. Arnold
Neurology 2003; 61: 1279-1281.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barré syndrome
- J. Pritchard, I. A. Gray, Z. R. Idrissova, B. R.F. Lecky, I. J. Sutton, A. V. Swan, H. J. Willison, J. B. Winer, and R. A.C. Hughes
Neurology 2003; 61: 1282-1284.
[Abstract]
[Full text]
[PDF]
- ARTICLES
A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A
- B. Voller, T. Sycha, B. Gustorff, L. Schmetterer, S. Lehr, H. G. Eichler, E. Auff, and P. Schnider
Neurology 2003; 61: 940-944.
[Abstract]
[Full text]
[PDF]
- SPECIAL ARTICLES
Practice parameter: Immunotherapy for Guillain–Barré syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology
- R.A.C. Hughes, E.F.M. Wijdicks, R. Barohn, E. Benson, D.R. Cornblath, A. F. Hahn, J.M. Meythaler, R.G. Miller, J.T. Sladky, and J.C. Stevens
Neurology 2003; 61: 736-740.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
ALS treatment strikes out while trying for a homer: The topiramate trial
- Petra Kaufmann and Catherine Lomen-Hoerth
Neurology 2003; 61: 434-435.
[Full text]
[PDF]
- ARTICLES
A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis
- M.E. Cudkowicz, J.M. Shefner, D.A. Schoenfeld, R.H. Brown, Jr., H. Johnson, M. Qureshi, M. Jacobs, J.D. Rothstein, S.H. Appel, R.M. Pascuzzi, T.D. Heiman-Patterson, P.D. Donofrio, W.S. David, J.A. Russell, R. Tandan, E.P. Pioro, K.J. Felice, J. Rosenfeld, R.N. Mandler, G.M. Sachs, W.G. Bradley, E.M. Raynor, G.D. Baquis, J.M. Belsh, S. Novella, J. Goldstein, and J. Hulihan
Neurology 2003; 61: 456-464.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Donepezil in vascular dementia: A randomized, placebo-controlled study
- D. Wilkinson, R. Doody, R. Helme, K. Taubman, J. Mintzer, A. Kertesz, and R.D. Pratt
Neurology 2003; 61: 479-486.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Nondopaminergic symptomatic therapies for Parkinson’s disease: Turn on or turn off?
- Andrew Feigin
Neurology 2003; 61: 286-287.
[Full text]
[PDF]
- ARTICLES
Adenosine A2A receptor antagonist treatment of Parkinson’s disease
- W. Bara-Jimenez, A. Sherzai, T. Dimitrova, A. Favit, F. Bibbiani, M. Gillespie, M.J. Morris, M.M. Mouradian, and T.N. Chase
Neurology 2003; 61: 293-296.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD
- Robert A. Hauser, Jean P. Hubble, Daniel D. Truong, and the Istradefylline US-001 Study Group
Neurology 2003; 61: 297-303.
[Abstract]
[Full text]
[PDF]
|
|
